Sequential Skin Ltd, a biotech start-up behind a novel patch-based skin analysis of genetics and the skin microbiome—has raised $1.65 million in its oversubscribed seed round. The investment will be used to extend the company’s B2B offering to skincare, haircare and healthcare companies, adding to the 12 major clients currently using Sequential Skin.     In making the announcement, Sequential Skin said it will also be rolling out a consumer product, with a focus on expanding into the US via Ne...